Sun Pharma Advanced Research Company Limited (BOM:532872)
150.10
-1.90 (-1.25%)
At close: Jul 31, 2025
Beacon Roofing Supply Revenue
In the fiscal year ending March 31, 2025, Sun Pharma Advanced Research Company had annual revenue of 717.66M INR, down -5.00%. Sun Pharma Advanced Research Company had revenue of 271.86M in the quarter ending March 31, 2025, with 64.21% growth.
Revenue
717.66M
Revenue Growth
-5.00%
P/S Ratio
67.76
Revenue / Employee
2.27M
Employees
316
Market Cap
48.63B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 717.66M | -37.79M | -5.00% |
Mar 31, 2024 | 755.45M | -1.63B | -68.36% |
Mar 31, 2023 | 2.39B | 1.02B | 73.98% |
Mar 31, 2022 | 1.37B | -1.16B | -45.74% |
Mar 31, 2021 | 2.53B | 1.76B | 229.31% |
Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries | 9,765.41B |
HDFC Bank | 2,736.06B |
Bharti Airtel | 1,729.85B |
Tata Consultancy Services | 2,561.48B |
ICICI Bank | 2,054.85B |
State Bank of India | 3,429.39B |
Infosys | 1,672.76B |
Hindustan Unilever | 639.28B |
Sun Pharma Advanced Research Company News
- 2 months ago - SPARC shares drop nearly 20% after key drug trial fails - Business Upturn
- 2 months ago - SPARC shares fall over 13% in trade today: Details here - Business Upturn
- 4 months ago - Stock Market Today: Rajesh Exports, SCI, RHIM, SPARC, and KEC among top 5 gainers on March 20, 2025 - Business Upturn
- 8 months ago - SPARC signs binding LOI with UCSF and Tiller Therapeutics for pre-clinical oncology asset - Business Upturn
- 9 months ago - Sun Pharma Advanced Research Q2 revenue at Rs 12.86 crore; net loss widens to Rs 107.33 crore - Business Upturn